Биомаркеры повреждения кишечной стенки при синдроме мультиорганной дисфункции

Закрыть метаданные

Рекомендуем статьи по данной теме:

Фиброз печени при неалкогольной жировой болезни печени: роль адипокинов и неинвазивной оценки состояния кишечного барьера. Доказательная гастроэнтерология. 2023;(2):46-54

У пациентов, находящихся в тяжелом состоянии в отделении реанимации и интенсивной терапии (ОРИТ), из-за нарушений микроциркуляции, ишемии и гипоксии стенки кишечника увеличивается ее проницаемость, нарушается барьерная функция, вследствие чего бактерии и/или их эндотоксины проникают через поврежденный барьер слизистой оболочки кишечника. Это еще больше усиливает иммунный ответ, который становится системным и в конечном счете может привести к синдрому мультиорганной дисфункции, сепсису и даже летальному исходу. В данном обзоре рассмотрены механизмы нарушения кишечного барьера, а также наиболее надежные биомаркеры повреждения кишечной стенки, определяемые в сыворотке крови: зонулин (zonulin), кишечный белок, связывающий жирные кислоты (Intestinal fatty acidbinding protein — I-FABP), регенерирующий белок островкового происхождения 3-альфа (Regenerating islet-derived 3-alpha — REG3α), цитруллин (citrulline). Несмотря на различные ограничения исследований, эти биомаркеры являются интересными кандидатами для выявления пациентов с высоким риском развития осложнений и позволят проводить скрининг отдельных пациентов на предмет своевременных мер интенсивной терапии, которые могут сократить пребывание пациентов в ОРИТ и снизить летальность.

Ключевые слова:

синдром мультиорганной дисфункции

MODS

биомаркеры повреждения кишечной стенки

I-FABP

REG3α

зонулин

цитруллин

Авторы:

Тургунов Е.М.

НАО «Медицинский университет Караганды»

ORCID: 0000-0002-6486-3847

Огизбаева А.В.

НАО «Медицинский университет Караганды»

ORCID: 0000-0003-1006-1870

Мугазов М.М.

НАО «Медицинский университет Караганды»

ORCID: 0000-0002-7739-8999

Асамиданова С.Г.

НАО «Медицинский университет Караганды»

ORCID: 0000-0002-9819-3079

Дата поступления:

03.11.2023

Дата принятия в печать:

12.12.2023

Список литературы:

Asim M, Amin F, El-Menyar A. Multiple organ dysfunction syndrome: Contemporary insights on the clinicopathological spectrum. Qatar Medical Journal. 2020;(1):22. https://doi.org/10.5339/qmj.2020.22
Adelman MW, Woodworth MH, Langelier C, Busch LM, Kempker JA, Kraft CS, Kraft CS, Martin GS, Martin GS. The Gut Microbiome’s Role in the Development, Maintenance, and Outcomes of Sepsis. Critical Care. 2020;24(1):278. https://doi.org/10.1186/s13054-020-02989-1
Tyszko M, Lema´nska-Perek A, ´Smiechowicz J, Tomaszewska P, Biecek P, Gozdzik W, Adamik B. Citrulline, Intestinal Fatty Acid-Binding Protein and the Acute Gastrointestinal Injury Score as Predictors of Gastrointestinal Failure in Patients with Sepsis and Septic Shock. Nutrients. 2023;15(9):2100. https://doi.org/10.3390/nu15092100
Assimakopoulos SF, Triantos C, Thomopoulos K. Fligou F, Maroulis I, Marangos M, Gogos CA. Gut-origin sepsis in the critically ill patient: pathophysiology and treatment. Infection. 2018;46(6):751-760. https://doi.org/10.1007/s15010-018-1178-5
Alukal JJ, Thuluvath PJ. Gastrointestinal Failure in Critically Ill Patients with Cirrhosis. American Journal of Gastroenterology. 2019;114(8):1231-1237. https://doi.org/10.14309/ajg.0000000000000226
Wang F, Li Q, Wang C, Tang C, Li J. Dynamic alteration of the colonic microbiota in intestinal ischemia-reperfusion injury. PLoS One. 2012;7(7):e42027. https://doi.org/10.1371/journal.pone.0042027
Stubljar D. Effective Strategies for Diagnosis of Systemic Inflammatory Response Syndrome (SIRS) due to Bacterial Infection in Surgical Patients. Infectious Disorders Drug Targets. 2015;15(1):53-56. https://doi.org/10.2174/1871526515666150320161804
Clark JA, Coopersmith CM. Intestinal crosstalk: A new paradigm for understanding the gut as the ‘motor’ of critical illness. Shock. 2007;28(4):384-393. https://doi.org/10.1097/shk.0b013e31805569df
Assimakopoulos SF, Papageorgiou I, Charonis A. Enterocytes tight junctions: from molecules to diseases. World Journal of Gastrointestinal Pathophysiology. 2011;2(6):123-137. https://doi.org/10.4291/wjgp.v2.i6.123
Anand RJ, Leaphart CL, Mollen KP, Hackam DJ. The role of the intestinal barrier in the pathogenesis of necrotizing enterocolitis. Shock. 2007;27(2):124-133. https://doi.org/10.1097/01.shk.0000239774.02904.65
Vaishnavi C. Translocation of gut ﬂora and its role in sepsis. Indian Journal of Medical Microbiology. 2013;31(4):334-342. https://doi.org/10.4103/0255-0857.118870
Brennan CA, Garrett WS. Gut microbiota, inflammation, and colorectal cancer. Annual Review of Microbiology. 2016;70:395-411. https://doi.org/10.1146/annurev-micro-102215-095513
Fasano A. Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications. Clinical Gastroenterology and Hepatology. 2012;10(10):1096-1100. https://doi.org/10.1016/j.cgh.2012.08.012
Fasano A, Not T, Wang W, Uzzau S, Berti I, Tommasini A, Goldblum SE. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet. 2000;355(9214):1518-1519. https://doi.org/10.1016/S0140-6736(00)02169-3
Ajamian M, Steer D, Rosella G, Gibson PR. Serum zonulin as a marker of intestinal mucosal barrier function: May not be what it seems. PLoS One. 2019;14(1):e0210728. https://doi.org/10.1371/journal.pone.0210728
Wells JM, Brummer RJ, Derrien M, MacDonald TT, Troost F, Cani PD, Theodorou V, Dekker J, Méheust A, de Vos WM, Mercenier A, Nauta A, Garcia-Rodenas CL. Homeostasis of the gut barrier and potential biomarkers. American Journal of Physiology: Gastrointestinal and Liver Physiology. 2017;312(3):G171-G93. https://doi.org/10.1152/ajpgi.00048.2015
Fasano A. All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases. F1000Res. 2020;9:F1000 Faculty Rev-69. https://doi.org/10.12688/f1000research.20510.1
Jayashree B, Bibin YS, Prabhu D, Shanthirani CS, Gokulakrishnan K, Lakshmi BS, Mohan V, Balasubramanyam M. Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes. Molecular and Cellular Biochemistry. 2014;388(1-2):203-210. https://doi.org/10.1007/s11010-013-1911-4
Esnafoglu E, Cırrık S, Ayyıldız SN, Erdil A, Ertürk EY, Daglı A, Noyan T. Increased Serum Zonulin Levels as an Intestinal Permeability Marker in Autistic Subjects. Journal of Pediatrics. 2017;188:240-244. https://doi.org/10.1016/j.jpeds.2017.04.004
Ouyang J, Yan J, Zhou X, Isnard S, Harypursat V, Cui H, Routy J-P, Chen Y. Relevance of biomarkers indicatinggut damage and microbial translocation inpeople living with HIV. Frontiers in Immunology. 2023;14:1173956. https://doi.org/10.3389/fimmu.2023.1173956
Giron LB, Dweep H, Yin X, Wang H, Damra M, Goldman AR, Gorman N, Palmer CS, Tang H-Y, Shaikh MW, Forsyth CB, Balk RA, Zilberstein NF, Liu Q, Kossenkov A, Keshavarzian A, Landay A, Abdel-Mohsen M. Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients. Frontiers in Immunology. 2021;12:686240. https://doi.org/10.3389/fimmu.2021.686240
Klaus DA, Motal MC, Burger-Klepp U, Marschalek C, Schmidt EM, Lebherz-Eichinger D, Krenn CG, Roth GA. Increased plasma zonulin in patients with sepsis. Biochemia Medica. 2013;23(1):107-111. https://doi.org/10.11613/BM.2013.013
Liu Z, Li C, Huang M, Tong C, Zhang X, Wang L, Peng H, Lan P, Zhang P, Huang N, Peng J, Wu X, Luo Y, Qin H, Kang L, Wang J. Positive regulatory effects of perioperative probiotic treatment on postoperative liver complications after colorectal liver metastases surgery: a double-center and double-blind randomized clinical trial. BMC Gastroenterology. 2015;15:34. https://doi.org/10.1186/s12876-015-0260-z
Assimakopoulos SF, Akinosoglou K, de Lastic A-L, Skintzi A, Mouzaki A, Gogos CA. The prognostic value of endotoxemia and intestinal barrier biomarker ZO-1 in bacteremic sepsis. American Journal of Medical Sciences. 2019;359(2):100-107. https://doi.org/10.1016/j.amjms.2019.10.006
Sturgeon C, Fasano A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers. 2016;4(4):e1251384. https://doi.org/10.1080/21688370.2016.1251384
Buttet M, Traynard V, Tran TT, Besnard P, Poirier H, Niot I. From fatty-acid sensing to chylomicron synthesis: role of intestinallipid-binding proteins. Biochimie. 2014;96:37-47. https://doi.org/10.1016/j.biochi.2013.08.011
Piton G, Capellier G. Biomarkers of gut barrier failure in the icu. Current Opinion in Critical Care. 2016;22(2):152-160. https://doi.org/10.1097/MCC.0000000000000283
Keenan JI, Day AS. The Role of Gastrointestinal-Related Fatty Acid-Binding Proteins as Biomarkers in Gastrointestinal Diseases. Digestive Diseases and Sciences. 2020;65(2):376-390. https://doi.org/10.1007/s10620-019-05841-x
Shaaban A, Alfqy O, Shaaban H, A-Maqsoud Y, Assar E. Potential Role of Serum Intestinal Fatty Acid-Binding Protein as a Marker for Early Prediction and Diagnosis of Necrotizing Enterocolitis in Preterm Neonates. Journal of Indian Association of Pediatric Surgeons. 2021;26(6):393-400. https://doi.org/10.4103/jiaps.JIAPS_218_20
Voth M, Duchene M, Auner B, Lustenberger T, Relja B, Marzi I. I-FABP is a novel marker for the detection of intestinal injury in severely injured trauma patients. World Journal of Surgery. 2017;41(12):3120-3127. https://doi.org/10.1007/s00268-017-4124-2
Voth M, Lustenberger T, Relja B, Marzi I. Is I-FABP not only a marker for the detection abdominal injury but also of hemorrhagic shock in severely injured trauma patients? World Journal of Emergency Surgery. 2019;14:49. https://doi.org/10.1186/s13017-019-0267-9
Kastl SP, Krychtiuk KA, Lenz M, Distelmaier K, Goliasch G, Huber K, Wojta J, Heinz G, Speidl WS. Intestinal fatty acid binding protein is associated with mortality in patients with acute heart failure or cardiogenic shock. Shock. 2019;51(4):410-415. https://doi.org/10.1097/SHK.0000000000001195
Sekino M, Okada K, Funaoka H, Sato S, Ichinomiya T, Higashijima U, Matsumoto S, Yoshitomi O, Eishi K, Hara T. Association between enterocyte injury and mortality in patients on hemodialysis who underwent cardiac surgery: an exploratory study. Journal of Surgical Research. 2020;255:420-427. https://doi.org/10.1186/s12871-021-01515-2
Sekino M, Funaoka H, Sato S, Okada K, Inoue H, Yano R, Matsumoto S, Ichinomiya T, Higashijima U, Matsumoto S, Hara T. Association between macroscopic tongue ischemia and enterocyte injury and poor outcome in patients with septic shock: a preliminary observational study. Shock. 2018;50(5):530-537. https://doi.org/10.1097/SHK.0000000000001122
Matsumoto S, Sekine K, Funaoka H, Yamazaki M, Shimizu M, Hayashida K, Kitano M. Diagnostic performance of plasma biomarkers in patients with acute intestinal ischaemia. British Journal of Surgery. 2014;101(3):232-238. https://doi.org/10.1002/bjs.9331
Костина О.В., Диденко Н.В., Галова Е.А., Пушкин А.С., Загреков В.И., Ашкинази В.И., Преснякова М.В. Белок, связывающий жирные кислоты, как маркер повреждения кишечника и потенциальный предиктор летального исхода в острый период ожоговой болезни. Анестезиология и реаниматология. 2023;(6):52-57. https://doi.org/10.17116/anaesthesiology202306152
Tyszko M, Lipinska-Gediga M, Lemanska-Perek A, Kobylinska K, Gozdzik W, Adamik B. Intestinal Fatty Acid Binding Protein (I-FABP) as a Prognostic Marker in Critically Ill COVID-19 Patients. Pathogens. 2022;11(12):1526. https://doi.org/10.3390/pathogens11121526
Zou L, Song X, Hong L, Shen X, Sun J, Zhang C, Mu X. Intestinal fatty acid-binding protein as a predictor of prognosis in postoperative cardiac surgery patients. Medicine. 2018;97(33):e11782. https://doi.org/10.1097/MD.0000000000011782
Yokoyama H, Sekino M, Funaoka H, Sato S, Araki H, Egashira T, Yano R, Matsumoto S, Ichinomiya T, Higashijima U, Hara T. Association between enterocyte injury and fluid balance in patients with septic shock:a post hoc exploratory analysis of a prospective observational study. BMC Anesthesiology. 2021;21(1):293. https://doi.org/10.1186/s12871-021-01515-2
Ogden HB, Fallowfield JL, Child RB, Davison G, Fleming SC, Edinburgh RM, Delves SK, Millyard A, Westwood CS, Layden JD. Reliability of gastrointestinal barrier integrity and microbial translocation biomarkers at rest and following exertional heat stress. Physiological Reports. 2020;8(5):e14374. https://doi.org/10.14814/phy2.14374
Ho SSC, Keenan JI, Day AS. The Role of Gastrointestinal-Related Fatty Acid-Binding Proteins as Biomarkers in Gastrointestinal Diseases. Digestive Diseases and Sciences. 2020;65(2):376-390. https://doi.org/10.1007/s10620-019-05841-x
Chaaban H, Patel MM, Burge K, Eckert JV, Lupu C, Keshari RS, Silasi R, Regmi G, Trammell M, Dyer D, McElroy SJ, Lupu F. Early antibiotic exposure alters intestinal development and increases susceptibility to necrotizing enterocolitis: A mechanistic study. Microorganisms. 2022;10(3):519. https://doi.org/10.3390/microorganisms10030519
Liu TC, Kern JT, Jain U, Sonnek NM, Xiong S. Simpson KF, Van Dussen KL, Winkler ES, Haritunians T. Malique A. Western diet induces Paneth cell defects through microbiome alterations and farnesoid X receptor and type I interferon activation. Cell Host Microbe. 2021;29(6):988-1001. https://doi.org/10.1016/j.chom.2021.04.004
Cray P, Sheahan BJ, Dekaney CM. Secretory sorcery: Paneth cell control of intestinal repair and homeostasis. Cellular and Molecular Gastroenterology and Hepatology. 2021;12(4):1239-1250. https://doi.org/10.1016/j.jcmgh.2021.06.006
Barreto EBL. Rattes IC, Da CA, Gama, P. Paneth cells and their multiple functions. Cell Biology International. 2022;46(5):701-710. https://doi.org/10.1002/cbin.11764
Yang W, Yuan Q, Li Z, Du Z, Wu G, Yu J, Hu J. Translocation and Dissemination of Gut Bacteria after Severe Traumatic Brain Injury. Microorganisms. 2022;10(10):2082. https://doi.org/10.3390/microorganisms10102082
Shin JH, Seeley RJ. Reg3 proteins as gut hormones? Endocrinology. 2019;160(6):1506-1514. https://doi.org/10.1210/en.2019-00073
Chen Z, Downing S, Tzanakakis ES. Four decades after the discovery of regenerating islet-derived (Reg) proteins: current understanding and challenges. Frontiers in Cell and Developmental Biology. 2019;7:235. https://doi.org/10.3389/fcell.2019.00235
Isnard S, Ramendra R, Dupuy FP, Lin J, Fombuena B, Kokinov N, Kema I, Jenabian MA, Lebouché B, Costiniuk CT, Ancuta P, Bernard NF, Silverman MS, Lakatos PL, Durand M, Tremblay C, Routy JP; Montreal Primary HIV Infection Study, the Canadian Cohort of HIV+ Slow Progressors, and the Canadian HIV and Aging Cohort Groups. Plasma levels of c-type lectin REG3alpha and gut damage in people with human immunodeficiency virus. Scandinavian Journal of Infectious Diseases Supplementum. 2020;221(1):110-121. https://doi.org/10.1093/infdis/jiz423
Darnaud M, Dos Santos A, Gonzalez P, Augui S, Lacoste C, Desterke C, De Hertogh G, Valentino E, Braun E, Zheng J, Boisgard R, Neut C, Dubuquoy L, Chiappini F, Samuel D, Lepage P, Guerrieri F, Doré J, Bréchot C, Moniaux N, Faivre J. Enteric delivery of regenerating family member 3 alpha alters the intestinal microbiota and controls inflammation in mice with colitis. Gastroenterology. 2018;154(4):1009-1023. https://doi.org/10.1053/j.gastro.2017.11.003
Bluemel S, Wang L, Martino C, Lee S, Wang Y, Williams B, Horvath A, Stadlbauer V, Zengler K, Schnabl B. The role of intestinal c-type regenerating islet derived-3 lectins for nonalcoholic steatohepatitis. Hepatology Communications. 2018;2(4):393-406. https://doi.org/10.1002/hep4.1165
Yang J, Syed F, Xia Y, Sanyal AJ, Shah VH, Chalasani N, Zheng X, Yu Q, Lou Y, Li W. Blood biomarkers of intestinal epithelium damage regenerating islet-derived protein 3alpha and trefoil factor 3 are persistently elevated in patients with alcoholic hepatitis. Alcoholism, Clinical and Experimental Research. 2021;45(4):720-731. https://doi.org/10.1111/acer.14579
Zhao D, Kim YH, Jeong S, Greenson JK, Chaudhry MS, Hoepting M, Anderson ER, van den Brink MR, Peled JU, Gomes AL, Slingerland AE, Donovan MJ, Harris AC, Levine JE, Ozbek U, Hooper LV, Stappenbeck TS, Ver Heul A, Liu TC, Reddy P, Ferrara JL. Survival signal REG3alpha prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease. The Journal of Clinical Investigation. 2018;128(11):4970-4979. https://doi.org/10.1172/JCI99261
Zhang N, Gou Y, Liang S, Chen N, Liu Y, He Q, Zhang J. Dysbiosis of Gut Microbiota romotes Hepatocellular Carcinoma Progression by Regulating the Immune Response. Journal of Immunology Research. 2021;4973589. https://doi.org/10.1155/2021/4973589
Fragkos KC, Forbes A. Citrulline as a marker of intestinal function and absorption in clinical settings: a systematic review and meta-analysis. United European Gastroenterology Journal. 2018;6(2):181e91. https://doi.org/10.1177/2050640617737632
Kartaram S, Mensink M, Teunis M, Schoen E, Witte G, Janssen Duijghuijsen L, Verschuren M, Mohrmann K, M’Rabet L, Knipping K, Wittink H, van Helvoort A, Garssen J, Witkamp R, Pieters R, van Norren K. Plasma citrulline concentration, a marker for intestinal functionality, reflects exercise intensity in healthy young men. Clinical Nutrition. 2019;38(5):2251-2258. https://doi.org/10.1016/j.clnu.2018.09.029
Howarth C, Banerjee J, Eaton S, Aladangady N. Biomarkers of gut injury in neonates — where are we in predicting necrotising enterocolitis? Frontiers in Pediatrics. 2022;10:1048322. https://doi.org/10.3389/fped.2022.1048322
Bajaj JS, Vargas HE, Reddy KR, Lai JC, O’Leary JG, Tandon P, Wong F, Mitrani R, White MB, Kelly M, Fagan A, Patil R, Sait S, Sikaroodi M, Thacker LR, Gillevet PM. Association between intestinal microbiota collected at hospital admission and outcomes of patients with cirrhosis. Clinical Gastroenterology and Hepatology. 2019;17(4):756-765. https://doi.org/10.1016/j.cgh.2018.07.022
Katell P, Nuzzo, Guedj A, Paugam K, Paugam C, Corcos O. Diagnosis biomarkers in acute intestinal ischemic injury: so close, yet so far. Clinical Gastroenterology and Hepatology. 2018;56(3):373-385. https://doi.org/10.1515/cclm-2017-0291

Закрыть метаданные